Circular RNAs emerge as important regulators with great potential for clinical application in gastric cancer

Biomark Med. 2021 Jan;15(1):69-82. doi: 10.2217/bmm-2020-0591. Epub 2020 Nov 13.

Abstract

Gastric cancer (GC) is a common digestive malignancy with a high-ranking morbidity and mortality. Therefore, it is urgent to identify novel indicators and develop new strategies for clinical diagnosis and treatment of GC. As a type of noncoding RNA, circular RNAs (circRNAs) have received increased attention in GC during recent years. To more comprehensively understand current research progress on circRNAs in GC, in this review, we introduce basic knowledge of circRNAs, summarize abnormally expressed circRNAs and discuss their functions and regulatory molecular mechanisms in GC. Then, we review potential applications of circRNAs for GC diagnosis, prognosis and treatment. Finally, we conclude by highlighting major advancements of circRNAs in GC research, and we discuss existing challenges and possible future research directions of GC-associated circRNAs.

Keywords: circular RNA; clinical application; gastric cancer; oncogenic or tumor-suppressive role; regulatory molecular mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Humans
  • Prognosis
  • RNA, Circular*
  • RNA, Untranslated
  • Stomach Neoplasms*

Substances

  • Biomarkers, Tumor
  • RNA, Circular
  • RNA, Untranslated